KELLIE MYERS: Open Payments
NPI 1083215800 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,322 in 177 payments from 38 companies in 2025. Trend: 2023 $2,523 · 2024 $3,776 · 2025 $4,322
Food & beverage: $4,213Education: $109
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 29 | $795 |
| ABBVIE INC. | 6 | $245 |
| TerSera Therapeutics LLC | 8 | $206 |
| Tempus AI, Inc | 13 | $206 |
| Merck Sharp & Dohme LLC | 9 | $194 |
| Astellas Pharma US Inc | 12 | $190 |
| AstraZeneca Pharmaceuticals LP | 7 | $182 |
| Daiichi Sankyo Inc. | 8 | $170 |
| Ipsen Biopharmaceuticals, Inc | 3 | $165 |
| Novartis Pharmaceuticals Corporation | 7 | $155 |
Products named: RYBREVANT, XT CDX, KEYTRUDA, TALVEY, ENHERTU, XTANDI, TECVAYLI, Vonjo.
Industry payments across TX — which companies pay providers there.
